吉晟生技股份有限公司 Approved
最後更新時間 2025/04/15 , 01:34 PM
最後更新時間 2025/04/15 , 01:34 PM
負責人
Yang,Chao-Tang
統一編號
53541504
成立日期
2011/10/03
資本額
NT$800,000,000
實收資本額
NT$505,294,000
股票代號
7762
電話
02-29087790
地址
1F, No. 141, Hougang 1st Rd., Xinzhuang Dist., New Taipei City, 242, Taiwan
網站
董監事
姓名 職稱 持有股份 代表法人
Yang,Chao-Tang Chairman 8.31% Veritas Biomedical Co. Ltd.
Lin,Liang-Guang Director 8.31% Veritas Biomedical Co. Ltd.
Chen,Ji-Guang Director 5.77% BECQUEREL & SIEVERT CO., LTD.
Jiang,Zheng-Qi Director 5.32% GIDDI PHARMA CO., LTD.
Cai,Shi-Chen Independent Director 0.00%
Huang,Shi-Ying Independent Director 0.00%
Qian,Ying-Long Independent Director 0.00%
營業項目
  • Manufacture of Drugs and Medicines(200211)
  • 公司歷程
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2024/06/19
  • Change Company Name to JISHENG BIOTECHNOLOGY CO., LTD. (FORMER NAME: SHIXUAN BIOTECHNOLOGY CO., LTD.)
    2023/03/10
  • Change Capital to 600,000,000
    2023/03/10
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2022/02/23
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2022/02/23
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2022/02/17
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2022/02/17
  • Change Person in Charge to Yang,Chao-Tang
    2022/02/17
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2021/07/15
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2021/07/15
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2021/05/12
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2020/06/09
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2019/10/30
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2019/10/30
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2019/09/05
  • Change Person in Charge to Chen,Ji-Guang
    2019/09/05
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2018/09/03
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2018/09/03
  • Change Person in Charge to Jiang,Nai-Jing
    2018/09/03
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2018/08/07
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2017/01/13
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2017/01/13
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2016/12/22
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2016/12/22
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2016/12/19
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2016/12/19
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2016/08/17
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2016/08/17
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2016/03/07
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2016/03/07
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2015/11/06
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2015/09/30
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2015/07/09
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2015/06/16
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2015/04/17
  • Change Person in Charge to Gao,Zhi-Hao
    2015/04/17
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2014/09/19
  • Change Capital to 350,000,000
    2014/09/19
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2013/05/20
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2013/05/20
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2013/04/01
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2013/04/01
  • Change Capital to 100,000,000
    2013/04/01
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2012/11/26
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2012/11/14
  • Change Capital to 60,000,000
    2012/11/14
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2012/10/30
  • Change Capital to 40,000,000
    2012/10/30
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2012/10/08
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2012/10/08
  • Change Capital to 30,000,000
    2012/10/08
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2012/09/04
  • Change Company Name to PET PHARM BIOTECH CO., LTD.
    2012/08/20
  • Change Company Name to SHIXUAN BIOTECHNOLOGY CO., LTD. (FORMER NAME: PEIFAN BIOTECHNOLOGY CO., LTD.)
    2012/08/20
  • Change Capital to 20,000,000
    2012/06/11
  • 員工人數
    財務報表
    項目 2024 2023
    Operating income 55,936 117,866
    Operating cost 26,704 53,274
    Profit (loss) of initial recognition of biological asset and agricultural products - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - -
    Operating gross profit (loss) 29,232 64,592
    Unrealized profit (loss) on sales of goods - -
    Realized profit (loss) on sales of goods - -
    Operating gross profit (loss), net 29,232 64,592
    Operating expenses 27,768 57,005
    Other gain (loss), net - -
    Operating profit (loss) 1,464 7,587
    Non-operating income and expenses 1,901 1,562
    Net profit (loss) before tax 3,365 9,149
    Income tax expense (benefits) 0 0
    Net profit (loss) of ongoing business for the current period 3,365 9,149
    Profit (loss) of closed units - -
    Profit (loss) of non-jointly controlled equity before merger - -
    Net profit (loss) for the current period 3,365 9,149
    Other comprehensive profit (loss), net - 0
    Comprehensive net profit and loss of non-jointly controlled equity before merger - -
    Total comprehensive profit and loss for the current period 3,365 9,149
    Net profit (loss) attributable to owners of parent company - -
    Net profit (loss) form equity attributable to former owner of business combination under common control - -
    Net profit (loss) attributable to non-controlling interests - -
    Comprehensive profit (loss) attributable to owners of parent company - -
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - -
    Comprehensive profit (loss) attributable to non-controlling interests - -
    Basic earnings per share (yuan) 0 0
    項目 2024 2023
    Net cash inflow (outflow) from operating activities - -
    Net cash inflows (outflows) from investing activities - -
    Net cash inflow (outflow) from financing activities - -
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - -
    Increase (decrease) in cash and cash equivalents in the current period - -
    Beginning balance of cash and cash equivalents - -
    Ending balance of cash and cash equivalents - -
    項目 2024 2023
    Current asset 363,298 354,404
    Non-current asset 298,922 133,173
    Total asset 662,220 487,577
    Current liability 135,488 32,309
    Non-current liability 39,371 41,630
    Total liability 174,859 73,939
    share capital 405,294 371,899
    Equity - secruity token - -
    capital reserve 78,702 150,005
    retained earning 3,365 -108,266
    Other equity 0 0
    Treasury stock - -
    Total equity attributable to owners of parent company - -
    Equity attributable to former owner of business combination under common control - -
    Equity attributable to non-controlling interest before business merger under common control - -
    Non-controlling interests - -
    Total Equity 487,361 413,638
    Share capital awaiting retirement (unit: share) 0 0
    Issued shares of advance equity (unit: shares) 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0
    Net asset value per share 12 11
    動產抵押
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    存款不足之退票事宜
    時間 金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
    專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。